This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why a Buy Strategy is Apt for Waste Management (WM) Now
by Zacks Equity Research
Waste Management (WM) continues to execute core operating initiatives targeting focused differentiation and continuous improvement.
Here's Why You Should Hold on to Green Dot (GDOT) Stock For Now
by Zacks Equity Research
Green Dot's (GDOT) long-standing relationship with Walmart remains a key driver of its operating revenues.
Here's Why You Should Retain Xerox (XRX) Stock for Now
by Zacks Equity Research
Post-sale-driven business model and strong margins boost Xerox (XRX). However, decreasing current ratio is a headwind.
Envestnet (ENV) to Benefit From Its Redi2 Buyout: Here's How
by Zacks Equity Research
The buyout makes Envestnet (ENV) one of the leading providers of revenue and billing tools required by advisors, wealth firms and asset managers.
Here's Why You Should Retain S&P Global (SPGI) Stock for Now
by Zacks Equity Research
Strategic buyouts as well as investor-favorite moves boost S&P Global (SPGI). However, decreasing current ratio is a headwind.
Xerox (XRX) to Benefit From Its Go Inspire Buyout: Here's How
by Zacks Equity Research
The acquisition should help Xerox (XRX) expand its Digital Services business and bring more innovation to its solutions.
Here's Why Investors Should Buy ICF International (ICFI) Now
by Zacks Equity Research
Strategic acquisitions and a strong balance sheet are aiding ICF International (ICFI) stock.
Reasons to Retain Maximus (MMS) Stock in Your Portfolio For Now
by Zacks Equity Research
With more than 40 years of experience, Maximus (MMS) has grown to be a leading operator of government health and human services programs globally.
6 Reasons to Add Paychex (PAYX) Stock to Your Portfolio Now
by Zacks Equity Research
Paychex's (PAYX) efforts to capitalize on the rising opportunities in the professional employer organization industry look impressive. Acquisitions help boost revenue growth.
G vs. PAYX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
G vs. PAYX: Which Stock Is the Better Value Option?
Zacks Industry Outlook Highlights Automatic Data Processing, Paychex and Genpact
by Zacks Equity Research
Automatic Data Processing, Paychex and Genpact have been highlighted in this Industry Outlook article.
3 Stocks to Watch From the Promising Outsourcing Space
by Sanjana Goswami
The Zacks Outsourcing industry seeks to benefit from the coronavirus-driven dependency on technology and accelerated adoption of cloud infrastructure. ADP, PAYX and G are well-positioned to witness the surge in demand.
6 Reasons Why Investors Should Buy Genpact (G) Stock Now
by Zacks Equity Research
Acquisitions have helped Genpact (G) expand its portfolio and gain new domain expertise. Artificial Intelligence offers the company solid growth opportunities.
4 Reasons to Buy Cross Country Healthcare (CCRN) Stock Now
by Zacks Equity Research
Cross Country Healthcare (CCRN) is currently benefiting from its investments in headcount and technology.
G or PAYX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
G vs. PAYX: Which Stock Is the Better Value Option?
Why Genpact (G) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
G vs. PAYX: Which Stock Is the Better Value Option?
by Zacks Equity Research
G vs. PAYX: Which Stock Is the Better Value Option?
Zacks Industry Outlook Highlights Automatic Data Processing, Paychex, and Genpact
by Zacks Equity Research
Automatic Data Processing, Paychex, and Genpact are part of Zacks Industry Outlook article.
3 Outsourcing Stocks to Strengthen Your Portfolio Now
by Sanjana Goswami
As the industry seeks to benefit from the COVID-driven reliance on technology and the accelerated uptake of cloud infrastructure, investing in outsourcing stocks like ADP, PAYX, G can be a prudent move.
Wall Street Analysts Believe Genpact (G) Could Rally 31%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 30.9% in Genpact (G). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
G vs. PAYX: Which Stock Is the Better Value Option?
by Zacks Equity Research
G vs. PAYX: Which Stock Is the Better Value Option?
Genpact (G) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Genpact (G) delivered earnings and revenue surprises of 13.21% and 3.65%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
ExlService Holdings (EXLS) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
ExlService Holdings (EXLS) delivered earnings and revenue surprises of 8.40% and 7.16%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights Lockheed Martin, Boeing, Northrop Grumman, General Dynamics and Huntington Ingalls Industries
by Zacks Equity Research
Lockheed Martin, Boeing, Northrop Grumman, General Dynamics and Huntington Ingalls Industries are part of today's Analyst Blog.
Workday (WDAY) to Help Expand Genpact's Global Business
by Zacks Equity Research
The Workday (WDAY) platform will help drive process standardization across Genpact's teams to ensure secure data access for better decision-making.